CUREVAC VACCINE DISAPPOINTS IN KEY STUDY AMID ‘UNPRECEDENTED’ SPREAD OF VARIANTS

Dive Brief: An experimental coronavirus vaccine from drugmaker CureVac was only 47% effective at preventing COVID-19 in a preliminary analysis of results from a large clinical trial, a disappointing result that the German biotech company attributed to the widespread prevalence of virus variants.   According to CureVac, the efficacy estimate could change as more of […]